Altered GABA and secondary bile acids in Guillain-Barré syndrome: association with gut dysbiosis
-
By
-
Jiafang Fu
-
Jingli Shan
-
Hua Xu
-
Zhiwei Zhu
-
Pengshuo Yang
-
Qinzhou Wang
-
Jinxiang Han
-
Guangxiang Cao
-
June 10, 2026
-
Clinical Scorecard: Changes in GABA Levels and Secondary Bile Acids in Guillain-Barré Syndrome: Links to Gut Dysbiosis
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Altered GABA metabolism and secondary bile acid metabolism associated with gut dysbiosis; specify the relationship. |
| Target Population | |
| Care Setting | |
Key Highlights
- GABA levels increased approximately 14.3-fold in GBS subjects; discuss implications for diagnosis.
- Multiple secondary cholic acids were significantly decreased in GBS subjects; explain clinical relevance.
Guideline-Based Recommendations
Diagnosis
Management
- Investigate modulation of gut microbiota as a therapeutic approach in GBS; suggest specific interventions.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
GABA analogues may be relevant in managing symptoms related to nerve function; provide supporting evidence.
Clinical Best Practices
- Utilize metabolomics and metagenomics for comprehensive assessment of GBS; detail implementation strategies.
Related Resources & Content
